These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 37450687)
1. Combination of 3PO analog PFK15 and siPFKL efficiently suppresses the migration, colony formation ability, and PFK-1 activity of triple-negative breast cancers by reducing the glycolysis. Kashyap A; Umar SM; Dev J R A; Mathur SR; Gogia A; Batra A; Deo SVS; Prasad CP J Cell Biochem; 2023 Sep; 124(9):1259-1272. PubMed ID: 37450687 [TBL] [Abstract][Full Text] [Related]
2. Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma. Li HM; Yang JG; Liu ZJ; Wang WM; Yu ZL; Ren JG; Chen G; Zhang W; Jia J J Exp Clin Cancer Res; 2017 Jan; 36(1):7. PubMed ID: 28061878 [TBL] [Abstract][Full Text] [Related]
3. Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma. Yang K; Qiu T; Zhou J; Gong X; Zhang X; Lan Y; Zhang Z; Ji Y J Transl Med; 2023 Feb; 21(1):85. PubMed ID: 36740704 [TBL] [Abstract][Full Text] [Related]
4. Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancer. Umar SM; Kashyap A; Kahol S; Mathur SR; Gogia A; Deo SVS; Prasad CP Exp Cell Res; 2020 Nov; 396(1):112282. PubMed ID: 32919954 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer. O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609 [TBL] [Abstract][Full Text] [Related]
6. Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3). Emini Veseli B; Perrotta P; Van Wielendaele P; Lambeir AM; Abdali A; Bellosta S; Monaco G; Bultynck G; Martinet W; De Meyer GRY FEBS Lett; 2020 Sep; 594(18):3067-3075. PubMed ID: 32620030 [TBL] [Abstract][Full Text] [Related]
7. The synergistic effect of PFK15 with metformin exerts anti-myeloma activity via PFKFB3. Liu X; Zhao Y; Zhang E; Yan H; Lv N; Cai Z Biochem Biophys Res Commun; 2019 Jul; 515(2):332-338. PubMed ID: 31153642 [TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer. Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of 6-phosphofructo-2-kinase suppresses fibroblast-like synoviocytes-mediated synovial inflammation and joint destruction in rheumatoid arthritis. Zou Y; Zeng S; Huang M; Qiu Q; Xiao Y; Shi M; Zhan Z; Liang L; Yang X; Xu H Br J Pharmacol; 2017 May; 174(9):893-908. PubMed ID: 28239846 [TBL] [Abstract][Full Text] [Related]
10. Role of Akt/PKB and PFKFB isoenzymes in the control of glycolysis, cell proliferation and protein synthesis in mitogen-stimulated thymocytes. Houddane A; Bultot L; Novellasdemunt L; Johanns M; Gueuning MA; Vertommen D; Coulie PG; Bartrons R; Hue L; Rider MH Cell Signal; 2017 Jun; 34():23-37. PubMed ID: 28235572 [TBL] [Abstract][Full Text] [Related]
11. Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy. Li X; Liu J; Qian L; Ke H; Yao C; Tian W; Liu Y; Zhang J Mol Cell Biochem; 2018 Aug; 445(1-2):123-134. PubMed ID: 29327288 [TBL] [Abstract][Full Text] [Related]
13. PFKP deubiquitination and stabilization by USP5 activate aerobic glycolysis to promote triple-negative breast cancer progression. Peng ZM; Han XJ; Wang T; Li JJ; Yang CX; Tou FF; Zhang Z Breast Cancer Res; 2024 Jan; 26(1):10. PubMed ID: 38217030 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of glycolytic activator PFKFB3 suppresses tumor growth and induces tumor vessel normalization in hepatocellular carcinoma. Matsumoto K; Noda T; Kobayashi S; Sakano Y; Yokota Y; Iwagami Y; Yamada D; Tomimaru Y; Akita H; Gotoh K; Takeda Y; Tanemura M; Umeshita K; Doki Y; Eguchi H Cancer Lett; 2021 Mar; 500():29-40. PubMed ID: 33307155 [TBL] [Abstract][Full Text] [Related]
15. Sonic hedgehog stimulates glycolysis and proliferation of breast cancer cells: Modulation of PFKFB3 activation. Ge X; Lyu P; Gu Y; Li L; Li J; Wang Y; Zhang L; Fu C; Cao Z Biochem Biophys Res Commun; 2015 Aug; 464(3):862-8. PubMed ID: 26171876 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of miR-206 suppresses glycolysis, proliferation and migration in breast cancer cells via PFKFB3 targeting. Ge X; Lyu P; Cao Z; Li J; Guo G; Xia W; Gu Y Biochem Biophys Res Commun; 2015 Aug; 463(4):1115-21. PubMed ID: 26093295 [TBL] [Abstract][Full Text] [Related]
17. PFK15, a Small Molecule Inhibitor of PFKFB3, Induces Cell Cycle Arrest, Apoptosis and Inhibits Invasion in Gastric Cancer. Zhu W; Ye L; Zhang J; Yu P; Wang H; Ye Z; Tian J PLoS One; 2016; 11(9):e0163768. PubMed ID: 27669567 [TBL] [Abstract][Full Text] [Related]